News

2019

company

year

domain

Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL747 For Alzheimer’s Disease

Denali Therapeutics 02.15.2019

Moderna Announces Positive Interim Phase 1 Data for First Combination Vaccine Against the Respiratory Viruses hMPV and PIV3

Moderna 02.12.2019

GlaxoSmithKline Scientist Steps Down to Join Flagship Pioneering

Flagship Pioneering 02.07.2019

Moderna Announces Dosing of the First Monoclonal Antibody Encoded by mRNA in a Clinical Trial

Moderna 02.05.2019

Torque and Thermo Fisher Scientific Announce Collaboration to Build State-of-the-Art Facility to Manufacture Torque's Deep-Primed T Cell Immunotherapies

02.04.2019

Sigilon Therapeutics Expands Intellectual Property Portfolio with New Patent Issued

Sigilon Therapeutics 01.30.2019

Evelo Biosciences Announces Dosing of First Patient in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA® in Patients with Metastatic Melanoma

Evelo Biosciences 01.28.2019

Torque Appoints John Cox as Executive Chairman to Board of Directors and Lisa Butterfield, PhD, to Scientific Advisory Board

01.25.2019

Dr. John Mendlein to Transition to an Advisory Role at Moderna and Join Flagship Pioneering as an Executive Partner

Moderna 01.18.2019

Seres Therapeutics Announces Chief Executive Officer Transition

Seres Therapeutics 01.15.2019

Loading